| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 46.97▼ | 46.75▲ | 46.74▲ | 46.37▲ | 44.45▲ |
| MA10 | 46.87▲ | 46.68▲ | 46.63▲ | 45.88▲ | 44.90▲ |
| MA20 | 46.77▲ | 46.56▲ | 46.51▲ | 44.51▲ | 41.22▲ |
| MA50 | 46.67▲ | 46.39▲ | 46.21▲ | 44.44▲ | 37.61▲ |
| MA100 | 46.62▲ | 46.16▲ | 44.97▲ | 40.81▲ | 36.25▲ |
| MA200 | 46.48▲ | 44.78▲ | 44.86▲ | 38.05▲ | 43.40▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.026▲ | 0.021▲ | 0.036▲ | 0.219▲ | 0.373▲ |
| RSI | 63.130▲ | 58.125▲ | 58.182▲ | 65.439▲ | 66.634▲ |
| STOCH | 78.268 | 45.401 | 64.528 | 83.925▲ | 74.378 |
| WILL %R | -35.849 | -30.638 | -14.201▲ | -7.547▲ | -3.371▲ |
| CCI | 68.248 | 105.328▲ | 104.509▲ | 99.216 | 81.051 |
|
Friday, July 26, 2024 12:52 PM
Billionaire Bill Ackman’s investment fund Pershing Square USA has postponed its U.S. closed end fund’s initial public offering.
|
|
Friday, July 26, 2024 12:13 PM
Silo Pharma (NASDAQ: SILO) , a developmental-stage biopharmaceutical company focused on developing
|
|
Thursday, July 25, 2024 06:00 AM
Japanese Patent Office approved Inventiva’s patent application relating to the use of lanifibranor for the treatment of cirrhosis.1This patent strengthens Inventiva’s intellectual property with ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/07/24 | 46.75 | 47.30 | 46.33 | 46.92 | 5,541,837 |
| 25/07/24 | 44.65 | 46.50 | 44.5227 | 46.22 | 12,605,748 |
| 24/07/24 | 45.54 | 47.30 | 44.97 | 46.28 | 15,253,287 |
| 23/07/24 | 46.09 | 46.18 | 45.52 | 45.92 | 5,522,132 |
| 22/07/24 | 45.90 | 46.68 | 45.76 | 46.49 | 6,366,406 |
| 19/07/24 | 45.70 | 46.04 | 45.49 | 45.72 | 4,219,169 |
| 18/07/24 | 45.715 | 46.22 | 45.49 | 45.87 | 4,296,619 |
| 17/07/24 | 45.30 | 46.11 | 45.15 | 45.75 | 7,110,961 |
| 16/07/24 | 44.16 | 45.58 | 44.04 | 45.51 | 5,715,918 |
| 15/07/24 | 43.68 | 44.255 | 43.44 | 44.14 | 4,808,513 |
|
|
||||
|
|
||||
|
|